Company / Shareholders' Equity
Apyx Medical Corp Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$14.5M
FY2025
5-year range
$14.2M / $53.7M
FY2021-FY2025
Trend
+2.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity returned to growth in FY2025 after 4 years of decline, reaching $15M.
Based on SEC 10-K filings.
$15M in FY2025 with a 5-year CAGR of -25.6%.
Declined from $27M to $15M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -27.1%
- 5-Year CAGR
- -25.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -25.6%, indicating a declining trend.
- In FY2025, shareholders' equity increased 2.3% year-over-year.
- Peak shareholders' equity was recorded in FY2020.
- Lowest shareholders' equity in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.5M | +2.3% |
| FY2024 | $14.2M | -46.8% |
| FY2023 | $26.7M | -29.0% |
| FY2022 | $37.6M | -30.0% |
| FY2021 | $53.7M | -15.7% |
| FY2020 | $63.7M | +143.0% |
| FY2019 | $26.2M | +0.0% |
| FY2018 | $26.2M | +12.0% |
| FY2017 | $23.4M | +1456.1% |
| FY2016 | $1.5M | -92.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026